- Home
- PHH vs AIMD Comparison
PHH vs AIMD Comparison
Compare PHH & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- AIMD
- Stock Information
- Founded
- PHH 2016
- AIMD 1984
- Country
- PHH China
- AIMD United States
- Employees
- PHH N/A
- AIMD N/A
- Industry
- PHH Package Goods/Cosmetics
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- AIMD Health Care
- Exchange
- PHH Nasdaq
- AIMD Nasdaq
- Market Cap
- PHH 16.2M
- AIMD 16.9M
- IPO Year
- PHH 2024
- AIMD N/A
- Fundamental
- Price
- PHH $0.38
- AIMD $3.99
- Analyst Decision
- PHH
- AIMD
- Analyst Count
- PHH 0
- AIMD 0
- Target Price
- PHH N/A
- AIMD N/A
- AVG Volume (30 Days)
- PHH 386.5K
- AIMD 79.2K
- Earning Date
- PHH 08-26-2025
- AIMD 11-05-2025
- Dividend Yield
- PHH N/A
- AIMD N/A
- EPS Growth
- PHH N/A
- AIMD N/A
- EPS
- PHH N/A
- AIMD N/A
- Revenue
- PHH $2,768,120.00
- AIMD $110,870.00
- Revenue This Year
- PHH N/A
- AIMD N/A
- Revenue Next Year
- PHH N/A
- AIMD N/A
- P/E Ratio
- PHH N/A
- AIMD N/A
- Revenue Growth
- PHH 42.65
- AIMD 70.25
- 52 Week Low
- PHH $0.38
- AIMD $2.00
- 52 Week High
- PHH $41.49
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- PHH 25.95
- AIMD 57.32
- Support Level
- PHH $0.38
- AIMD $3.75
- Resistance Level
- PHH $0.43
- AIMD $4.44
- Average True Range (ATR)
- PHH 0.03
- AIMD 0.23
- MACD
- PHH 0.06
- AIMD 0.02
- Stochastic Oscillator
- PHH 9.08
- AIMD 56.31
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.